No high-quality human trial has shown that CBD treats gout, although preclinical work and studies in related arthritis suggest it may ease joint pain or inflammation for some people. If you take colchicine, NSAIDs or steroids, check for interactions first, and keep your total intake within the Food Standards Agency’s 10 mg a day advice. Speak to your clinician before you start.
TL;DR:
- The FSA advises healthy adults to keep total CBD from all food and supplement sources at or below 10 mg daily, including combined products.
- CBD can inhibit liver enzymes that process colchicine and other prescription medicines, potentially raising drug levels, so ask a clinician or pharmacist before combining them.
- During an acute flare, use prescribed NSAIDs, colchicine, or corticosteroids rather than delaying or replacing proven treatment with CBD, as directed by your clinician.
- Before buying, check milligrams per serving and container, and review a batch specific third party lab report for potency, THC, and contaminants.
Table of Contents
- 1. What does the research on CBD and gout actually show?
- 2. How might CBD influence gout symptoms?
- 3. What safety checks and drug interactions should you know about?
- 4. How do people try CBD for gout, and when?
- 5. How do you choose a safer CBD product?
- 6. Why I stay cautiously optimistic, but safety comes first
- 7. If you decide to try CBD, what do we offer?
- FAQ
- Sources
1. What does the research on CBD and gout actually show?
Here is the plain picture. We could not find a clinical trial that tested CBD specifically in people with gout. Patient-facing summaries say the same: no clinical studies directly support CBD for gout. What exists is a mix of laboratory work, animal studies and small studies in other joint conditions. That is interesting, but it is not proof.
The rheumatology community has noticed. Experts writing on cautious hope for CBD in rheumatology care describe the position as hopeful but preclinical. CBD shows anti-inflammatory effects in the lab, yet it lacks high-quality human trials and should not replace evidence-based gout treatments such as colchicine or NSAIDs. A separate review of joint disease research reaches a similar place: promising results in mouse models, mixed results in small clinical studies, and a clear call for better human trials.
So what does that mean when you are living with gout? A few things are worth holding onto:
- No gout-specific trials. Anything you read claiming CBD “treats” gout is running ahead of the evidence.
- Plausible, not proven. Preclinical findings explain why people try CBD for joint pain. They do not tell us how much helps, or whether it helps at all, in a gout flare.
- Related arthritis data is background only. Studies in other conditions can guide questions, but gout has its own cause: uric acid crystals in the joint.
- Proven care stays first. Urate-lowering therapy and flare treatments do the heavy lifting, and CBD would at most sit alongside them.
That last point matters most. Clinical gout guidance is clear that acute attacks are treated with NSAIDs, colchicine or corticosteroids, and that urate is managed with urate-lowering therapy. A gout management summary used in NHS prescribing makes the point that unproven remedies should not stand in for these medicines during a flare.
Then there is the safety side of the evidence, which is better documented than the benefit side. After reviewing the data, the Food Standards Agency (FSA) concluded that higher doses taken over time may affect the liver and thyroid. It now advises healthy adults to limit intake from all food and supplement sources, and you can read the detail in its updated consumer advice. The assessment behind that advice, a novel food safety assessment, set a provisional acceptable daily intake for high-purity CBD and recommended clear labelling so people do not stack several products and drift over the limit.
The FSA advises healthy adults to limit total CBD intake to 10 mg a day from all food and supplement sources, because higher doses over time may affect the liver and thyroid.
That sentence is worth reading twice if you are used to higher-strength products. A single capsule or gummy can sit well above the figure, so you will need to do some label arithmetic. We cover that in the product section below.
Where does this leave you? Treat CBD as an experiment with a low ceiling on dose and a high bar for safety, not as a gout treatment. If you want a structured way to run a time-limited trial for another condition, our research trial plan template shows the kind of note-taking approach we like, and the same discipline applies here.
2. How might CBD influence gout symptoms?
Gout pain comes from inflammation. Uric acid crystals settle in a joint, the immune system reacts, and the area becomes hot, swollen and exquisitely tender. Anything that calms inflammatory signalling or dulls pain pathways is, in theory, of interest. That is the logic behind looking at CBD, and it is worth being clear that this is a hypothesis, not a result.
Researchers have pointed to several pathways that might matter:
- The endocannabinoid system. This network of receptors helps regulate pain and immune responses, and CBD interacts with it indirectly.
- TRP channels. These are receptors involved in sensing pain and temperature, and CBD has been shown to act on some of them in the lab.
- PPAR-gamma. A receptor linked to inflammation control, which CBD can influence.
These mechanisms are described in the joint disease review we mentioned above, and they are discussed in more patient-friendly terms in a piece asking whether CBD oil works for gout. None of them has been demonstrated to work in a person having a gout flare.
What about the animal studies? In rodent arthritis models, CBD given topically or by mouth has been reported to reduce inflammatory markers and pain behaviours. That is the strongest “for” argument, and it deserves a fair hearing. It is also why you will see CBD discussed alongside joint pain at all.
But think about what those experiments actually involve. A mouse with an induced arthritis is not a person with a crystal-driven condition. The dose in the animal study may be far higher than anything you could take within UK advice. The way pain is measured differs, the injury is created differently, and the timescale is short. Put simply, animal results generate ideas. They do not predict human benefit.
A few honest limitations to keep in mind:
- Doses used in animal work are often much larger, relative to body weight, than the FSA limit would allow a person to take.
- Models of arthritis rarely reproduce the uric acid crystal process that defines gout.
- Pain outcomes in animals are behavioural, and they do not capture what a flare feels like.
- Small human studies in other conditions have given mixed results, as the reviews note.
Pro Tip: When you read a headline claiming “CBD reduces arthritis inflammation”, check whether the study was in mice, in cells, or in people, and whether the condition was gout or something else.
None of this makes the idea foolish. It makes it unfinished. If you hope CBD might take the edge off background joint discomfort between attacks, that is a reasonable thing to explore carefully. If someone promises it will stop a flare, that goes beyond what the science can support.
3. What safety checks and drug interactions should you know about?
Safety is where we want you to slow down, because for people with gout the medicine cabinet is often busy. Colchicine, NSAIDs, corticosteroids and urate-lowering drugs are all common, and CBD is not a bystander in the body’s chemistry.
CBD is processed by cytochrome P450 enzymes in the liver, and it can inhibit some of them. In practice, that may change how quickly the body clears other medicines. An analysis in the medical literature notes that CBD is not approved for gout and can interfere with the metabolism of prescription drugs such as colchicine, risking raised drug levels. The FSA says much the same in its food fact check on CBD: CBD can interact with common treatments, and people on prescription medication should seek medical advice, while pregnant or breastfeeding people and children should avoid it unless a doctor advises otherwise.
People taking prescription medication, and anyone who is pregnant or breastfeeding, are advised by the FSA to avoid CBD unless a doctor says otherwise.
We go deeper into this in our guide on how CBD interacts with medications, and it is worth a read before you speak to your pharmacist.
What about everyday side effects? Patient-facing summaries describe a generally favourable profile with mild effects such as diarrhoea, fatigue and sleepiness. The same summary flags drug interactions and inconsistent products as the practical risks. Concerns about the liver and thyroid relate to higher or prolonged doses, which is exactly why the FSA set its limit. Our article on CBD safety, overdose signs and lab tests explains what to watch for in more detail.
Here is a sensible order of play before you take your first dose:
- Review every medicine with a clinician or pharmacist. Include over-the-counter products and supplements, not just prescriptions.
- Ask whether a baseline liver test makes sense for you. Your clinician will know if it is advisable given your history and current drugs.
- Confirm you are not in a group advised to avoid CBD. That includes pregnancy, breastfeeding and anyone on certain prescription medicines.
- Work out your daily total before you buy. Add up CBD from every product, because the 10 mg figure covers all sources combined.
- Stop and call your clinician if anything feels wrong. Unusual tiredness, stomach upset that will not settle, or yellowing of the skin or eyes need prompt attention.
A final word for flare days. If you are mid-attack, the priority is treatment that is known to work. Do not swap or delay your prescribed flare medicine in favour of CBD, and tell your clinician if you have been using it.
4. How do people try CBD for gout, and when?
If you and your clinician agree that a cautious trial is reasonable, it helps to know the formats people use and how they differ.
Topicals such as balms and creams are applied to the skin over a sore joint. People choose them for local comfort, and they are the format most often discussed for localised joint pain. Oral products such as tinctures, capsules, tablets and gummies are swallowed and act more broadly. Each has a different onset and duration, and patient-facing guidance on CBD oil for gout notes that product inconsistency is a practical concern across formats.
A few practical differences:
- Balms and creams: applied where it hurts, easy to portion, but they do not count the same way as an oral dose and should still be discussed with your clinician if you use them regularly.
- Oils and tinctures: measured by drop or dropper, so you can fine-tune the amount, which suits a low and slow approach.
- Capsules and tablets: a fixed amount each time, simple to track, though many on the market are far stronger than the daily limit.
- Gummies and edibles: pleasant and easy to take, with the dose set per piece, so reading the label matters.
On dosing, the principle is modest. For oral food and supplement forms, aim to stay at or below the FSA’s 10 mg a day when you can. Start at the bottom, keep the trial short, and write down what happens to your pain and your sleep. Increase only with clinician supervision. A notebook or phone note is enough: date, product, dose, pain score, sleep quality, and any side effects.
Pro Tip: Change one thing at a time. If you start a new CBD product the same week as a new gout medicine, you will not know which one caused any change.
Timing is the other question. Between attacks, some people use CBD as a background measure for joint discomfort, which is the less risky place to experiment. During an acute flare, the answer is different. Flares call for evidence-based medicines, and clinical guidance is explicit that NSAIDs, colchicine or corticosteroids are the treatments for an acute attack. CBD should not take their place, and it should not be added without checking for interactions.
5. How do you choose a safer CBD product?
Most of the risk with CBD comes from not knowing what is in the bottle. The UK treats CBD products as novel foods, and the official CBD guidance makes clear that standards vary. That puts the burden of checking on you, so here is what to look for.
- Milligrams per serving and per container. You need both numbers to calculate your daily intake against the FSA limit. The agency also asks consumers to check labels, as set out in its consumer advice update.
- A third-party Certificate of Analysis (COA). It should show CBD potency and confirm THC is absent or within limits, ideally with contaminant testing for each batch. This is the strongest practical signal of trust.
- A clear statement of what the product is. Isolate, broad spectrum or full spectrum should be stated, with figures, not vague wording.
- Restrained claims. Avoid anything promising to cure, treat or reverse a condition. No CBD product can lawfully or honestly claim that for gout.
Here is a quick reference you can screenshot:
| What to check | Why it matters |
|---|---|
| mg per serving | Lets you stay within the 10 mg a day advice |
| Batch COA | Confirms potency and purity |
| THC result | Matters if you are tested or sensitive |
| Product type stated | Isolate or spectrum affects what you take |
| Plain claims | Cure claims are a red flag |
For a broader refresher on reading labels and common questions, our general CBD product FAQs are a good place to start.
6. Why I stay cautiously optimistic, but safety comes first
My honest view is that CBD for gout sits in an awkward middle. It is not a proven treatment, and I would not tell anyone it is. But the idea that it might ease background joint discomfort for some people is not unreasonable, given what we know from related conditions and lab work. What worries me is less the molecule and more the habit of reaching for it instead of the medicines that actually protect your joints. Treat the 10 mg limit, the medication review and the conversation with your clinician as fixed points, not optional extras. Then, if you still want to try, keep it small, keep it short and write it down. That way, you learn something real and your care team stays in the loop.
— Moheet
7. If you decide to try CBD, what do we offer?
If you and your clinician agree to a careful trial, we have built our range around the checks above, so you can follow the FSA’s advice with less guesswork. We make high-purity CBD isolate products that are THC-free and publish third-party lab results.
Products you may want to look at for joint use:
- Topical balms and creams for local application, including our CBD muscle and joint range and our vanilla balm.
- Broad spectrum oils in our CBD oil collection, measured by the drop so you can set a small dose.
- Measured edibles and tablets, including CBD gummies.
Whatever you choose, read the certificate of analysis for your batch, start at a low dose, and speak to your clinician before you begin. You can browse everything on our shop.
FAQ
Does CBD reduce inflammation in joints?
CBD has reduced inflammatory markers in animal arthritis models, which is why it is studied. Human evidence is limited and mixed, so it cannot be called a proven treatment for joint inflammation. A review of CBD in joint disease stresses the need for better human trials.
What stops gout pain immediately?
There is no instant fix, but acute flares are treated with NSAIDs, colchicine or corticosteroids, taken as your clinician advises. Starting treatment early in an attack generally helps most. CBD is not a substitute for these medicines.
Is it safe to take CBD and colchicine together?
Not without medical advice. CBD can inhibit liver enzymes that process colchicine, which may raise colchicine levels in the body. Ask your doctor or pharmacist before combining them, as the FSA’s fact check also advises.
How much CBD can I take each day?
The FSA advises healthy adults to keep total intake from all food and supplement sources to 10 mg a day. Add up every product you use, and speak to your clinician first if you take prescription medicines.
Sources
- Gov
- Food
- Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease



